Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Elsevier to Work with Heel for Mechanism-based Drug Action Discovery

Posted on January 6th, 2021 by in Pharma R&D

Elsevier, the data analytics business specialized in science and health, and Heel, a pharmaceutical company specialized in developing and manufacturing medicines made from natural ingredients, have recently completed a series of research projects with a focus on improving exploratory preclinical studies.

(more…)

Insights begin with clean, reusable data

Posted on August 24th, 2020 by in Pharma R&D

Good data practices lead to better research outcomes. To learn more about why clean, reusable data is critical to R&D, take a look at this helpful new infographic that demonstrates how Entellect is centered around the importance of reusable data, irrespective of scientific domain.

(more…)

The Dawn of a European Health Data Space – Challenges

Posted on July 16th, 2020 by in Pharma R&D

The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality.

(more…)

The Dawn of a European Health Data Space – Opportunities

Posted on July 9th, 2020 by in Pharma R&D

At the beginning of 2020, the European Commission introduced a β€œEuropean strategy for data.” The document proposes to bolster and advance the data economy in Europe with a view towards capturing β€œthe benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and convenient public services.”

(more…)

  1. 1
  2. 2
  3. 3
  4. …
  5. 5